Non-Steroidal Anti-inflammatory Drugs Decrease E2F1 Expression and Inhibit Cell Growth in Ovarian Cancer Cells

Epidemiological studies have shown that the regular use of non-steroidal anti-inflammatory (NSAIDs) drugs is associated with a reduced risk of various cancers. In addition, in vitro and experiments in mouse models have demonstrated that NSAIDs decrease tumor initiation and/or progression of several cancers. However, there are limited preclinical studies investigating the effects of NSAIDs in ovarian cancer. Here, we have studied the effects of two NSAIDs, diclofenac and indomethacin, in ovarian cancer cell lines and in a xenograft mouse model. Diclofenac and indomethacin treatment decreased cell growth by inducing cell cycle arrest and apoptosis. In addition, diclofenac and indomethacin reduced tumor volume in a xenograft model of ovarian cancer. To identify possible molecular pathways mediating the effects of NSAID treatment in ovarian cancer, we performed microarray analysis of ovarian cancer cells treated with indomethacin or diclofenac. Interestingly, several of the genes found downregulated following diclofenac or indomethacin treatment are transcriptional target genes of E2F1. E2F1 was downregulated at the mRNA and protein level upon treatment with diclofenac and indomethacin, and overexpression of E2F1 rescued cells from the growth inhibitory effects of diclofenac and indomethacin. In conclusion, NSAIDs diclofenac and indomethacin exert an anti-proliferative effect in ovarian cancer in vitro and in vivo and the effects of NSAIDs may be mediated, in part, by downregulation of E2F1.

[1]  J. Price.  Xenograft models in immunodeficient animals : I. Nude mice: spontaneous and experimental metastasis models. , 2001, Methods in molecular medicine.

[2]  A. Papavassiliou,et al.  Distinct expression patterns of the transcription factor E2F‐1 in relation to tumour growth parameters in common human carcinomas , 2004, The Journal of pathology.

[3]  M. Thun,et al.  Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. , 2009, The Lancet. Oncology.

[4]  G. Giaccone,et al.  Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells. , 2010, Lung cancer.

[5]  Y. Wang,et al.  Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion , 2010, Oncogene.

[6]  D. Suh,et al.  Significance of E2F-1 overexpression in epithelial ovarian cancer , 2007, International Journal of Gynecologic Cancer.

[7]  T. Narisawa,et al.  Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. , 1980, Gan.

[8]  K. Berlin,et al.  Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells. , 2004, Journal of Medicinal Chemistry.

[9]  A. Papavassiliou,et al.  Transcription factor E2F‐1 acts as a growth‐promoting factor and is associated with adverse prognosis in non‐small cell lung carcinomas , 2002, The Journal of pathology.

[10]  S. Kondo,et al.  Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression. , 2004, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[11]  Á. Lanas,et al.  Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice. , 2011, International journal of oncology.

[12]  Christian Marth,et al.  Clinical Relevance of E2F Family Members in Ovarian Cancer—An Evaluation in a Training Set of 77 Patients , 2007, Clinical Cancer Research.

[13]  Gianni Tognoni,et al.  Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials , 2012, The Lancet.

[14]  E. Hawk,et al.  Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention , 2011, Cancer Prevention Research.

[15]  J. Hoheisel,et al.  Transcript profiling identifies novel key players mediating the growth inhibitory effect of NS-398 on human pancreatic cancer cells. , 2011, European journal of pharmacology.

[16]  H. Nagasawa,et al.  Inhibition by indomethacin of spontaneous mammary tumorigenesis in SHN mice , 2005, Breast Cancer Research and Treatment.

[17]  M. Takemura,et al.  Non‐steroidal anti‐inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase‐2 protein expression in endometrial cancer cells , 2004, Cancer science.

[18]  M. Bhasin,et al.  Combinatorial Effect of Non-Steroidal Anti-inflammatory Drugs and NF-κB Inhibitors in Ovarian Cancer Therapy , 2011, PloS one.

[19]  W. Grizzle,et al.  Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  S. Chuang,et al.  The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells , 2010, Molecular carcinogenesis.

[21]  D. Trask,et al.  Relative non‐steroidal anti‐inflammatory drug (NSAID) antiproliferative activity is mediated through p21‐induced G1 arrest and E2F inhibition , 2007, Molecular carcinogenesis.

[22]  A. Monks,et al.  Metallothionein gene expression and resistance to cisplatin in human ovarian cancer , 1990, International journal of cancer.

[23]  M. Grunewald,et al.  Diclofenac Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer by Modulation of VEGF Levels and Arginase Activity , 2010, PloS one.

[24]  R. Bast,et al.  Stanniocalcin 1 and ovarian tumorigenesis. , 2010, Journal of the National Cancer Institute.

[25]  I. Bruns,et al.  The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway , 2011, Apoptosis.

[26]  K. Hu,et al.  In vitro and In vivo Effects and Mechanisms of Celecoxib-Induced Growth Inhibition of Human Hepatocellular Carcinoma Cells , 2005, Clinical Cancer Research.

[27]  A. Trentham-Dietz,et al.  Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity , 2008, British Journal of Cancer.

[28]  Gavin Brooks,et al.  Non‐steroidal anti‐inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycle , 2003, The Journal of pharmacy and pharmacology.

[29]  H. Kruth,et al.  Arrest of cultured cells in the G1 phase of the cell cycle by indomethacin. , 1979, The Journal of pharmacology and experimental therapeutics.

[30]  S. Baruchel,et al.  Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma , 2009, Oncogene.

[31]  T. Kudo,et al.  Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. , 1981, Cancer research.

[32]  V. Adhami,et al.  Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells. , 2001, Biochemical and biophysical research communications.

[33]  W. Gronwald,et al.  Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model , 2013, International journal of cancer.

[34]  Vincent Grégoire,et al.  Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect. , 2005, Cancer research.

[35]  Yung-Hyun Choi,et al.  Widdrol induces cell cycle arrest, associated with MCM down-regulation, in human colon adenocarcinoma cells. , 2010, Cancer letters.

[36]  B. Wiedenmann,et al.  Nonsteroidal anti‐inflammatory drugs inhibit growth of human neuroendocrine tumor cells via G1 cell‐cycle arrest , 2003, International journal of cancer.

[37]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[38]  N. Chen,et al.  Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1. , 2008, Oncology reports.

[39]  Jian-Bing Fan,et al.  Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. , 2009, Gynecologic oncology.